Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO4 |
Molecular Weight | 376.4617 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](C)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=FAOZLTXFLGPHNG-KNAQIMQKSA-N
InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1
Molecular Formula | C22H29FO4 |
Molecular Weight | 376.4617 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:04:21 UTC 2023
by
admin
on
Sat Dec 16 16:04:21 UTC 2023
|
Record UNII |
SV0CSG527L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175450
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
NDF-RT |
N0000175576
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QD07AB06
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
C05AA06
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
D07AB06
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QC05AA06
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QD07XB04
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
D10AA01
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
S01CA07
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QS01BA07
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
D07CB03
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QS01CB05
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
S01BB03
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QD07CB03
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QS01BB03
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QD10AA01
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-VATC |
QS01CA07
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
S01BA07
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
D07XB04
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
||
|
WHO-ATC |
S01CB05
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C29058
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
SV0CSG527L
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
FLUOROMETHOLONE
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
DB00324
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
7079
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
m5477
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB07720MIG
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
1208
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
4491
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
1278007
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
207-041-5
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
Fluorometholone
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
426-13-1
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
100000091928
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
9878
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
SV0CSG527L
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
DTXSID7047435
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL1200600
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
31625
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
33001
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
D005469
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY | |||
|
803
Created by
admin on Sat Dec 16 16:04:22 UTC 2023 , Edited by admin on Sat Dec 16 16:04:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |